
Carlyle acquires Seraphim’s TestPlant
The Carlyle Group has acquired London-based software diagnostics developer TestPlant from venture capital firm Seraphim Capital.
The deal provides an exit for British VC Seraphim Capital, as Carlyle takes a majority stake in TestPlant. The GP drew capital from its €657m Carlyle Europe Technology Partners III vehicle, which has now provided equity for four deals since it was launched in May 2014.
Carlyle will keep the company's existing management in place following the MBO and the GP expects to continue TestPlant's growth trend, which has seen it increase revenues tenfold over the past five years.
Previous funding
TestPlant raised a total of $2.56m in venture funding since it was founded, over two rounds.
London-based Seraphim led both rounds, first investing £1m in September 2008, followed by a further $500,000 in January 2009.
Company
Headquartered in London, TestPlant is a developer of software for testing software quality and responsiveness.
The company was founded in 2008 and has offices in the UK, the US, Germany and China.
People
The Carlyle Group – Michael Wand (managing director).
TestPlant – George Mackintosh (CEO).
Advisers
Equity – Travers Smith (Legal); KPMG (Financial due diligence); CIL (Commercial due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater